Hypertension detection, treatment and control: A call to action for cardiovascular specialists

Journal of the American College of Cardiology

Volumn 34, Issue 4, 1999, Pages 1360-1362

  Levy, Daniel ^h   Noel Bairey Merz, C ⁱ   Cody, Robert J ^a,g   Fouad Tarazi, Fetnat M ^b   Francis, Charles K ^c   Pfeffer, Marc A ^d   Scott, Neal A ^e   Swan, H J C ⁱ   Taylor, Malcolm P ⁱ   Weinberger, Myron H ^f  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e EMORY UNIVERSITY HOSPITAL   (United States)

^f INDIANA UNIVERSITY   (United States)

^g AMERICAN COLLEGE OF CARDIOLOGY   (United States)

^h NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; LIFESTYLE; PRIORITY JOURNAL; REVIEW; STROKE;

ADULT; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; HUMANS; HYPERTENSION; MASS SCREENING; PATIENT CARE TEAM; RISK FACTORS; UNITED STATES;

EID: 0033213635     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00385-X     Document Type: Review

References (17)

1. Burt VL, Culter JA, Higgins M, et al. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995;26:60-9.
2. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25: 305-13.
3. National Center for Health Statistics, Division of Vital Statistics, Public Use Data Tapes for U.S. mortality, 1970 to 1996. Hyattsville (MD): National Center for Health Statistics, 1997.
4. National Heart, Lung and Blood Institute. Morbidity and Mortality: 1998 Chartbook of Cardiovascular, Lung and Blood Diseases. Bethesda (MD): National Institutes of Health, 1998.
5. The Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997;157: 2413-46.
6. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
7. O'Donnell CJ, Ridker PM, Glynn RJ, et al. Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation 1997;95:1132-7.
8. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure: insights into the time course of and risk factors for hypertensive left ventricular dysfunction. JAMA 1996;275:1557-62.
9. Klag MJ, Whelton PK, Randall BI, et al. Blood pressure and end-stage renal disease in men. N Engl J Med;334:13-8.
10. Sagic A, Larson MG, Levy D. The natural history of borderline isolated systolic hypertension. N Engl J Med 1993;329:1912-7.
11. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990;335:827-38.
12. Gueyffier F, Boutitie F, Boissel JP, et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized controlled trials. The INDANA Investigators. Ann Intern Med 1997; 126:761-7.
13. Moser M, Herbert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996;27:1214-8.
14. Cutler J, Psaty BM, MacMahon S, Furberg CD. Public health issues in hypertension control: what has been learned from clinical trials. In: Laragh JH, Brenner BM, editors. Hypertension: Pathophysiology, Diagnosis and Treatment. New York: Raven Press, 1995:253-70.
15. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP): SHEP Cooperative Research Group. JAMA 1991; 265:3255-64.
16. Staessen JA, Fagard R, Thijs L, et al. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997;350:757-64.
17. The Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-83.